Jacomasso, Thiago; Ribas, Hennrique Taborda; Lima, Marina Trombetta 
; Konig, Michelle Silberspitz; Trindade, Edvaldo da Silva; Martinez, Glaucia Regina ; Sogayar, Mari Cleide ; Winnischofer, Sheila Maria Brochado
Source: Melanoma Research. Unidade: IQ
Subjects: MELANOMA, EXPRESSÃO GÊNICA, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOMASSO, Thiago et al. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, v. 30, n. 3, p. 223-234, 2020Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000650. Acesso em: 15 nov. 2024.APA
Jacomasso, T., Ribas, H. T., Lima, M. T., Konig, M. S., Trindade, E. da S., Martinez, G. R., et al. (2020). The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, 30( 3), 223-234. doi:10.1097/CMR.0000000000000650NLM
Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000650Vancouver
Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000650
